Cargando…
A Systematic Review of Cost-Effectiveness Studies of Newer Non-Insulin Antidiabetic Drugs: Trends in Decision-Analytical Models for Modelling of Type 2 Diabetes Mellitus
BACKGROUND: We performed a systematic overview of the cost-effectiveness analyses (CEAs) comparing Non-insulin antidiabetic drugs (NIADs) with other NIADs for the treatment of type 2 diabetes mellitus (T2DM), using decision-analytical modelling (DAM), focusing on both the economic results and the un...
Autores principales: | Laursen, Henrik Vitus Bering, Jørgensen, Emmelie Ploug, Vestergaard, Peter, Ehlers, Lars Holger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570198/ https://www.ncbi.nlm.nih.gov/pubmed/37410277 http://dx.doi.org/10.1007/s40273-023-01268-5 |
Ejemplares similares
-
The Cost of Flexible Bronchoscopes: A Systematic Review and Meta-analysis
por: Andersen, Carina Østervig, et al.
Publicado: (2022) -
Red carpeting the newer antidiabetics
por: Gude, Dilip
Publicado: (2012) -
Can quality improvement improve the quality of care? A systematic review of reported effects and methodological rigor in plan-do-study-act projects
por: Knudsen, Søren Valgreen, et al.
Publicado: (2019) -
Newer antidiabetic drugs and calorie restriction mimicry
por: Kalra, Sanjay, et al.
Publicado: (2016) -
The Newer Insulins
por: Morris, Noah
Publicado: (1940)